INHIBITOR OF DEOXYHYPUSINE HYDROXYLASE FOR THE TREATMENT AND PREVENTION OF RESPIRATORY VIRUS INFECTIONS

The disclosure relates to deoxyhypusine hydroxylase (DOHH) inhibitors for use in treating or preventing respiratory virus infections, such as infection with coronaviruses, human rhinoviruses, influenza viruses, human parainfluenza viruses, respiratory syncytial viruses or human metapneumoviruses. La...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHASE, Arthur, SORIAGA, Leah B, TSE, Winston C, STOKES, Neil Robert, GROSSE, Johannes, BARTHA, Istvan, TELENTI, Amalio
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosure relates to deoxyhypusine hydroxylase (DOHH) inhibitors for use in treating or preventing respiratory virus infections, such as infection with coronaviruses, human rhinoviruses, influenza viruses, human parainfluenza viruses, respiratory syncytial viruses or human metapneumoviruses. La divulgation concerne des inhibiteurs de désoxyhypusine hydroxylase (DOHH) destinés à être utilisés dans le traitement ou la prévention d'infections par le virus respiratoire, telles qu'une infection par des coronavirus, des rhinovirus humains, des virus de la grippe, des virus parainfluenza humains, des virus respiratoires syncytiaux ou des métapneumovirus humains.